-
摘要: 坏死性外耳道炎(necrotizing otitis externa，NOE)是一种罕见的累及外耳道甚至颅底的进行性感染性疾病，治疗不及时可导致严重的并发症，甚至死亡。本文结合目前国内外研究现状，将其病因、发病机制、临床表现、诊断和治疗等方面的最新进展进行综述，为临床诊治和未来研究提供参考。Abstract: Necrotizing otitis externa is a progressive infectious disease involving the external auditory canal and even the skull base, which can lead to serious complications and even death if not treated in time. In this paper, the latest advances in etiology, pathogenesis, clinical manifestations, diagnosis and treatment were reviewed based on previous literature, providing reference for clinical diagnosis, treatment and future research.
-
-
[1] Treviño González JL, Reyes Suárez LL, Hernández de León JE. Malignant otitis externa: An updated review[J]. Am J Otolaryngol, 2021, 42(2): 102894. doi: 10.1016/j.amjoto.2020.102894
[2] ByunYB, PatelJ, NguyenSA, et al. Necrotizing Otitis Externa: A Systematic Review and Analysis of Changing Trends[J]. Otol Neurotol, 2020, 41(8): 1004-1011. doi: 10.1097/MAO.0000000000002723
[3] Mader JT, Love J. Malignant external otitis[J]. Arch Otolar-yngol, 1982, 108: 38-40. doi: 10.1001/archotol.1982.00790490040011
[4] Glikson E, Sagiv D, Wolf M, et al. Necrotizing otitis externa: diagnosis, treatment, and outcome in a case series[J]. Diagn Microbiol Infect Dis, 2017, 87(1): 74-78. doi: 10.1016/j.diagmicrobio.2016.10.017
[5] Carfrae MJ, Kesser BW. Malignant otitis externa[J]. Otolaryngol Clin North Am, 2008, 41: 537-549. doi: 10.1016/j.otc.2008.01.004
[6] SchopperHK, HatchJL, MeyerTA. Propionibacterium acnes as an Emerging Pathogen in Skull Base Osteomyelitis: A Case Series[J]. Laryngoscope, 2018, 128(2): 332-335. doi: 10.1002/lary.26869
[7] Hobson CE, Moy JD, Byers KE, et al. Malignant otitis externa: evolving pathogens and implications for diagnosis and treatment[J]. Otolaryngol Head Neck Surg, 2014, 151(1): 112-116. doi: 10.1177/0194599814528301
[8] Wahbah Makhoul G, Mobarakai O, Manchandani U, et al. A Rare Case of Streptococcus Pneumoniae Causing Malignant Otitis Externa Complicated by Skull Base Osteomyelitis[J]. Cureus, 2022, 6, 14(6): e25692.
[9] Mion M, Bovo R, Marchese-Ragona R, et al. Outcome predictors of treatment effectiveness for fungal malignant external otitis: a systematic review[J]. Acta Otorhinolaryngol Ital, 2015, 35(5): 307-313. doi: 10.14639/0392-100X-669
[10] Parize P, chandesris Mo, lanternier F, et al. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review[J]. Antimicrob Agents Chemother, 2009, 53: 1048-1053. doi: 10.1128/AAC.01220-08
[11] walton J, Coulson C. Fungal malignant otitis externa with facial nerve palsy: tissue biopsy aids diagnosis[J]. Case rep otolayngol, 2014, 2014: 192318.
[12] Danjou W, Chabert P, Perpoint, T, et al. Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period[J]. J Antimicrob Chemother, 2022, 77(9): 2532-2535. doi: 10.1093/jac/dkac193
[13] PeledC, El-SeidS, Bahat-DinurA, et al. Necrotizing Otitis Externa—Analysis of 83 Cases: Clinical Findings and Course of Disease[J]. Otol Neurotol, 2019, 40(1): 56-62. doi: 10.1097/MAO.0000000000001986
[14] Sylvester MJ, Sanghvi S, Patel VM, et al. Malignant otitis externa hospitalizations: analysis of patient characteristics[J]. Laryngoscope, 2017, 127(10): 2328-2336. doi: 10.1002/lary.26401
[15] Bruschini L, Berrettini S, Christina C, Ferranti S, Fabiani S, Cavezza M, et al. Extensive skull base osteomyelitis secondary to malignant otitis externa[J]. J Int AdvOtol, 2019, 15(3): 463-465.
[16] Al-Noury K, Lotfy A. Computed tomography and magnetic resonance imaging findings before and after treatment of patients with malignant external otitis[J]. Eur Arch Otorhinolaryngol, 2011, 268(12): 1727-1734. doi: 10.1007/s00405-011-1552-8
[17] Huang KL, Lu CS. Skull base osteomyelitis presenting as Villaret's syndrome[J]. Acta Neurol Taiwan, 2006, 15(4): 255-258.
[18] Arsovic N, Radivojevic N, Jesic S, et al. Malignant Otitis Externa: Causes for Various Treatment Responses[J]. J Int Adv Otol, 2020, 16(1): 98-103. doi: 10.5152/iao.2020.7709
[19] Byun YJ, Patel J, Nguyen SA, et al. Necrotizing Otitis Externa: A Systematic Review and Analysis of Changing Trends[J]. Otol Neurotol, 2020, 41(8): 1004-1011. doi: 10.1097/MAO.0000000000002723
[20] Dabiri S, Karrabi N, Yazdani N, et al. Facial nerve paralysis in malignant otitis externa: comparison of the clinical and paraclinical findings[J]. Acta Otolaryngol, 2020, 140(12): 1056-1060. doi: 10.1080/00016489.2020.1808242
[21] Zonnour A, Jamshidi A, Dabiri S, et al. Predictive factors in treatment response of malignant external otitis[J]. Eur Arch Otorhinolaryngol, 2023, 280(1): 159-166. doi: 10.1007/s00405-022-07478-5
[22] Karantanas AH, Karantzas G, Katsiva V, et al. CT and MRI in malignant external otitis: a report of four cases[J]. Comput Med Imaging Graph, 2003, 27(1): 27-34. doi: 10.1016/S0895-6111(02)00052-6
[23] Peled C, Kraus M, Kaplan D. Diagnosis and treatment of necrotising otitis externa and diabetic foot osteomyelitis-similarities and differences[J]. J Laryngol Otol, 2018, 132(9): 775-779. doi: 10.1017/S002221511800138X
[24] Morales RE, Eisenman DJ, Raghavan P. Imaging Necrotizing Otitis Externa[J]. Semin Roentgenol, 2019, 54(3): 215-226. doi: 10.1053/j.ro.2019.04.002
[25] Kim DH, Kim SW, Hwang SW. Predictive value of radiologic studies for malignant otitis externa: a systematic review and meta-analysis[J]. Braz J Otorhinolaryngol, 2023, 89(1): 66-72. doi: 10.1016/j.bjorl.2021.08.011
[26] Sturm JJ, Stern Shavit S, Lalwani AK. What is the Best Test for Diagnosis and Monitoring Treatment Response in Malignant Otitis Externa?[J]. Laryngoscope, 2020, 130(11): 2516-2517. doi: 10.1002/lary.28609
[27] Moss WJ, Finegersh A, Narayanan A, et al. Meta-analysis Does Not Support Routine Traditional Nuclear Medicine Studies for Malignant Otitis[J]. Laryngoscope, 2020, 130(7): 1812-1816. doi: 10.1002/lary.28411
[28] Stern Shavit S, Bernstine H, Sopov V, et al. FDG-PEG/CT for diagnosis and follow-up of necrotizing(Malignant)external otitis[J]. Laryngoscope, 2019, 129(4): 961-966. doi: 10.1002/lary.27526
[29] van Kroonenburgh AMJL, van der Meer WL, Bothof RJP, et al. Advanced Imaging Techniques in Skull Base Osteomyelitis Due to Malignant Otitis Externa[J]. Curr Radiol Rep, 2018, 6(1): 3. doi: 10.1007/s40134-018-0263-y
[30] Mahdyoun P, Pulcini C, Gahide I, et al. Necrotizing otitis externa: A systematic review[J]. Otol Neurotol, 2013, 34: 620-629. doi: 10.1097/MAO.0b013e3182804aee
[31] Stapleton E, Watson G. Emerging themes in necrotising otitis externa: a scoping review of the literature 2011-2020 and recommendations for future research[J]. J Laryngol Otol, 2021, 26: 1-30.
[32] Hodgson SH, Sinclair VJ, Arwyn-Jones J, et al. Characteristics, management and outcome of a large necrotising otitis externa case series: need for standardised case definition[J]. J Laryngol Otol, 2022, 136(7): 604-610. doi: 10.1017/S002221512100462X
[33] Glikson E, Sagiv D, Wolf M, et al. Necrotizing otitis externa: diagnosis, treatment, and outcome in a case series[J]. Diagn Microbiol Infect Dis, 2017, 87(1): 74-78. doi: 10.1016/j.diagmicrobio.2016.10.017
[34] Levenson MJ, Parisier SC, Dolitsky J, et al. Ciprofloxacin: drug of choice in the treatment of malignant external otitis(MEO)[J]. Laryngoscope, 1991, 101: 821-824.
[35] Walton J, Coulson C. Fungal malignant otitis externa with facial nerve palsy: tissue biopsy aids diagnosis[J]. Case Rep Otolaryngol, 2014, 2014: 192318.
[36] Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 63: e1-60.
[37] Pichon M, Joly V, Argy N, et al. Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review[J]. Infection, 2020, 48(2): 193-203. doi: 10.1007/s15010-020-01394-8
[38] Frost J, Samson AD. Standardised treatment protocol for necrotizing otitis externa: retrospective case series and systematic literature review[J]. J Glob Antimicrob Resist, 2021, 26: 266-271. doi: 10.1016/j.jgar.2021.06.015
[39] Hasibi M, Ashtiani MK, Zarandi MM, et al. A Treatment Protocol for Management of Bacterial and Fungal Malignant External Otitis: A Large Cohort in Tehran, Iran[J]. Ann Otol Rhinol Laryngol, 2017, 126(7): 561-567.
[40] Omran AA, Garem HFE, Alem RKA. Recurrent malignant otitis externa: management and outcome[J]. Eur Arch Otorhinolaryngol, 2012, 269(3): 807-811.
[41] Peled C, Parra A, El-Saied S, et al. Surgery for necrotizing otitis externa—indications and surgical findings[J]. Eur Arch Otorhinolaryngol, 2020, 277(5): 1327-1334.
[42] Narozny W, Kuczkowski J, Stankiewicz C, et al. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment[J]. Eur Arch Otorhinolaryngol, 2006, 263(7): 680-684.
[43] Amaro CE, Espiney R, Radu L, et al. Malignant(necrotizing)externa otitis: the experience of a single hyperbaric centre[J]. Eur Arch Otorhinolaryngol, 2019, 276(7): 1881-1887.
[44] Byun YJ, Patel J, Nguyen SA, et al. Hyperbaric oxygen therapy in malignant otitis externa: A systematic review of the literature[J]. World J Otorhinolaryngol Head Neck Surg, 2020, 7(4): 296-302.
-
计量
- 文章访问数: 1040
- PDF下载数: 256
- 施引文献: 0
下载: